92 related articles for article (PubMed ID: 10087822)
1. [Current topics in the regulation of prostanoids--4. The feedback regulation by PPAR-gamma].
Ohara M; Sawa T
Masui; 1999 Feb; 48(2):146-51. PubMed ID: 10087822
[TBL] [Abstract][Full Text] [Related]
2. PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines.
Jiang C; Ting AT; Seed B
Nature; 1998 Jan; 391(6662):82-6. PubMed ID: 9422509
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of glial cell proinflammatory activities by peroxisome proliferator-activated receptor gamma agonist confers partial protection during antimyelin oligodendrocyte glycoprotein demyelination in vitro.
Duvanel CB; Honegger P; Pershadsingh H; Feinstein D; Matthieu JM
J Neurosci Res; 2003 Jan; 71(2):246-55. PubMed ID: 12503087
[TBL] [Abstract][Full Text] [Related]
4. Adipocyte differentiation is regulated by a prostaglandin liganded to the nuclear peroxisome proliferator-activated receptor.
Wolf G
Nutr Rev; 1996 Sep; 54(9):290-2. PubMed ID: 9009672
[TBL] [Abstract][Full Text] [Related]
5. [PPARs, cancer cells and inflammation].
Tomita K; Hanafusa T
Nihon Rinsho; 2000 Feb; 58(2):461-4. PubMed ID: 10707577
[TBL] [Abstract][Full Text] [Related]
6. Peroxisome proliferator-activated receptor-gamma agonist troglitazone protects against nondiabetic glomerulosclerosis in rats.
Ma LJ; Marcantoni C; Linton MF; Fazio S; Fogo AB
Kidney Int; 2001 May; 59(5):1899-910. PubMed ID: 11318962
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of human lung cancer cell growth by the peroxisome proliferator-activated receptor-gamma agonists through induction of apoptosis.
Tsubouchi Y; Sano H; Kawahito Y; Mukai S; Yamada R; Kohno M; Inoue K; Hla T; Kondo M
Biochem Biophys Res Commun; 2000 Apr; 270(2):400-5. PubMed ID: 10753637
[TBL] [Abstract][Full Text] [Related]
8. Peroxisome proliferator-activated receptor gamma (PPARgamma) ligands as bifunctional regulators of cell proliferation.
Na HK; Surh YJ
Biochem Pharmacol; 2003 Oct; 66(8):1381-91. PubMed ID: 14555212
[TBL] [Abstract][Full Text] [Related]
9. Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2, ligands of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), reduce ischaemia/reperfusion injury of the gut.
Cuzzocrea S; Pisano B; Dugo L; Ianaro A; Patel NS; Di Paola R; Genovese T; Chatterjee PK; Di Rosa M; Caputi AP; Thiemermann C
Br J Pharmacol; 2003 Sep; 140(2):366-76. PubMed ID: 12970094
[TBL] [Abstract][Full Text] [Related]
10. Agonists of peroxisome proliferator-activated receptor gamma inhibit cell growth in malignant melanoma.
Mössner R; Schulz U; Krüger U; Middel P; Schinner S; Füzesi L; Neumann C; Reich K
J Invest Dermatol; 2002 Sep; 119(3):576-82. PubMed ID: 12230498
[TBL] [Abstract][Full Text] [Related]
11. Regulation of murine macrophage proinflammatory and anti-inflammatory cytokines by ligands for peroxisome proliferator-activated receptor-gamma: counter-regulatory activity by IFN-gamma.
Alleva DG; Johnson EB; Lio FM; Boehme SA; Conlon PJ; Crowe PD
J Leukoc Biol; 2002 Apr; 71(4):677-85. PubMed ID: 11927655
[TBL] [Abstract][Full Text] [Related]
12. Potentiation of glucose uptake in 3T3-L1 adipocytes by PPAR gamma agonists is maintained in cells expressing a PPAR gamma dominant-negative mutant: evidence for selectivity in the downstream responses to PPAR gamma activation.
Nugent C; Prins JB; Whitehead JP; Savage D; Wentworth JM; Chatterjee VK; O'Rahilly S
Mol Endocrinol; 2001 Oct; 15(10):1729-38. PubMed ID: 11579205
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptor-gamma in thyroid eye disease: contraindication for thiazolidinedione use?
Starkey K; Heufelder A; Baker G; Joba W; Evans M; Davies S; Ludgate M
J Clin Endocrinol Metab; 2003 Jan; 88(1):55-9. PubMed ID: 12519830
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effects of peroxisome poliferator-activated receptor gamma on thyroid carcinoma cell growth.
Martelli ML; Iuliano R; Le Pera I; Sama' I; Monaco C; Cammarota S; Kroll T; Chiariotti L; Santoro M; Fusco A
J Clin Endocrinol Metab; 2002 Oct; 87(10):4728-35. PubMed ID: 12364466
[TBL] [Abstract][Full Text] [Related]
15. A novel method for analysis of nuclear receptor function at natural promoters: peroxisome proliferator-activated receptor gamma agonist actions on aP2 gene expression detected using branched DNA messenger RNA quantitation.
Burris TP; Pelton PD; Zhou L; Osborne MC; Cryan E; Demarest KT
Mol Endocrinol; 1999 Mar; 13(3):410-7. PubMed ID: 10076998
[TBL] [Abstract][Full Text] [Related]
16. Interdomain communication regulating ligand binding by PPAR-gamma.
Shao D; Rangwala SM; Bailey ST; Krakow SL; Reginato MJ; Lazar MA
Nature; 1998 Nov; 396(6709):377-80. PubMed ID: 9845075
[TBL] [Abstract][Full Text] [Related]
17. Expression of peroxisome proliferator-activated receptors (PPARs) in human urinary bladder carcinoma and growth inhibition by its agonists.
Yoshimura R; Matsuyama M; Segawa Y; Hase T; Mitsuhashi M; Tsuchida K; Wada S; Kawahito Y; Sano H; Nakatani T
Int J Cancer; 2003 May; 104(5):597-602. PubMed ID: 12594814
[TBL] [Abstract][Full Text] [Related]
18. The role of PPAR-gamma in macrophage differentiation and cholesterol uptake.
Moore KJ; Rosen ED; Fitzgerald ML; Randow F; Andersson LP; Altshuler D; Milstone DS; Mortensen RM; Spiegelman BM; Freeman MW
Nat Med; 2001 Jan; 7(1):41-7. PubMed ID: 11135614
[TBL] [Abstract][Full Text] [Related]
19. Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) activation suppresses ischemic induction of Egr-1 and its inflammatory gene targets.
Okada M; Yan SF; Pinsky DJ
FASEB J; 2002 Dec; 16(14):1861-8. PubMed ID: 12468449
[TBL] [Abstract][Full Text] [Related]
20. Suppression of inducible cyclooxygenase and nitric oxide synthase through activation of peroxisome proliferator-activated receptor-gamma by flavonoids in mouse macrophages.
Liang YC; Tsai SH; Tsai DC; Lin-Shiau SY; Lin JK
FEBS Lett; 2001 May; 496(1):12-8. PubMed ID: 11343698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
